YOUR NEXT STEP STARTS WITH A QUESTION

Find research.
Explore your possibilities.

Search ClinicalTrials.gov across Miami, the U.S. and the world. Understand the details, then decide what to ask.

Condition or diseaseTry diabetes, asthma or psoriasisCity, state or countryKeywords

Search source

Recruiting in Miami WCR Miami Healthy volunteers

Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.

WCR feed checked: Nov 11, 2026.

RecruitingNCT06979453

Listed in WCR’s Miami feed

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Phase 312 years - 17 yearsBirmingham, Alabama, United States +113

The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis

Updated Oct 27, 2026View study

TerminatedNCT06867094

Listed in WCR’s Miami feed

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

Colitis Ulcerative

Phase 218 years - 75 yearsSun City, Arizona, United States +100

This is a Phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of SAR441566 in adults with moderate-to-severe UC. The primary objective of this study is to assess ef…

Updated Oct 21, 2026View study

TerminatedNCT06637631

Listed in WCR’s Miami feed

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

Crohn's Disease

Phase 218 years - 75 yearsSun City, Arizona, United States +112

This is a phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of SAR441566 in adults with moderate to severe Crohn's Disease (CD). The primary objective of this stu…

Updated Oct 13, 2026View study

Active, not recruitingNCT06557772

Listed in WCR’s Miami feed

A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease

Coeliac Disease · Celiac Disease

Phase 218 years - 75 yearsScottsdale, Arizona, United States +104

This is a Phase 2a/b, randomized, double-blind, placebo-controlled, parallel-group, 6-arm study to evaluate the efficacy and safety of amlitelimab in adult participants with non-responsive celiac disease (NRCD) who are on a gluten free diet (GFD) wit…

Updated Aug 31, 2026View study

Studies per page

Retrieved from ClinicalTrials.gov: Nov 11, 2026. Overall study status may differ from a particular location’s status.

Advanced search: all registry fields

Build a precise search with any field in the registry’s published data model. Standard filters above remain active.

Search syntax guide ↗

Registry fieldMatchValue

Advanced expressionUse AND / OR, AREA[field] and SEARCH[Location] to match city and site status together.

Title or acronymOutcome measureSponsor or collaboratorLead sponsorStudy identifier searchPatient search termsExact NCT IDs, comma separatedRegistry synonym selectorsAdditional registry facet expressionProximity weighting expression

Additional API post-filters

Optional exact API syntax. These narrow the returned records further.

postFilter.overallStatuspostFilter.geopostFilter.idspostFilter.advancedpostFilter.synonymsfilter.geodistance(25.9121,-80.3226,50mi)

Custom sort (up to two fields)Choose a suggested field or combine two with a comma.

Find research.Explore your possibilities.

4 studies

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease

Find research.
Explore your possibilities.